Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

The document concludes that non-endocrine alopecia in pets varies in treatment effectiveness and often has a poor prognosis, especially in cats.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.